The North American Spine Society announced revised recombinant human bone morphogenetic protein-2 coverage recommendations for patients undergoing spinal fusion surgery, according to a press release.“ ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel synthetic bone graft showed noninferiority to ...
ZURICH, SWITZERLAND / ACCESSWIRE / January 4, 2024 / Kuros Biosciences, a leader in next generation bone graft technologies, announced today three advancements related to its MagnetOs portfolio of ...